COVID-19 discovery could open the door to new treatments for chronic lung diseases

University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells’ ability to repair the lungs, helping explain the lingering effects of long COVID. The findings suggest a new treatment approach for long COVID as well as other conditions, both short-term and chronic, caused by respiratory infections such as the … Read more

Researchers identify cause of post-COVID inflammatory shock in children

MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be life-threatening. Until now, however, the precise cause of the condition was unknown. Researchers at Charité – Universitätsmedizin Berlin and the German Rheumatology Research Center (DRFZ), an institute of the Leibniz Association, have identified that … Read more

Avimex’s Covid Patria Vaccine: Effective Trials Show Promise Against Omicron and Its Variants This article explores the clinical trials of the Avimex laboratory’s Covid Patria vaccine (AVX/COVID-12), highlighting its effectiveness against the Omicron variant and potential versatility against other strains. General Director Bernardo Lozano Dubernard discusses the vaccine’s current status and its capacity for production. Furthermore, it touches on the international scope and future applications, emphasizing the innovation within Mexico’s scientific community.

Avimex’s COVID-19 Patria Vaccine: An Insight into Clinical Trials and Its Impact Introduction The Avimex laboratory, led by General Director Bernardo Lozano Dubernard, has recently announced the successful… The post <p><strong>Avimex’s Covid Patria Vaccine: Effective Trials Show Promise Against Omicron and Its Variants</strong></p> <p>This article explores the clinical trials of the Avimex laboratory’s Covid Patria … Read more

COVID-19 pandemic caused significant loss of disability-free life in Europe

Among 289 million adults in 18 European countries, more than 16 million years of life were lost from 2020 through 2022 due to the COVID-19 pandemic, according to a new study published March 11th in the open-access journal PLOS Medicine by Sara Ahmadi-Abhari of Imperial College London, UK, and colleagues. The direct and indirect impacts … Read more

Measles cases surge in Europe amid vaccine gaps

Data presented in the monthly measles and rubella update by the European Centre for Disease Prevention and Control (ECDC) indicate ongoing transmission of measles across a number of countries in EU/EEA, with a steep rise in cases reported during 2024. After a period of unusually low measles activity during the COVID-19 pandemic, an uptick was … Read more

Study warns 21 million children missed measles shots in 2022

Millions of children are slipping through the cracks of global vaccination efforts — and measles, one of the deadliest and most contagious diseases, is being overlooked. New research calls for urgent action to put measles vaccination at the center of global health priorities. Commentary: Missed Measles Immunisations Places Individuals and Communities at Risk: The Equity … Read more

Impact of maternal COVID-19 infection on offspring immunity and maternal-fetal outcomes at different pregnancy stages: a cohort study | BMC Pregnancy and Childbirth

Cui X, Wang Y, Zhai J, Xue M, Zheng C, Yu L. Future trajectory of SARS-CoV-2: constant spillover back and forth between humans and animals. Virus Res. 2023;328:199075. https://doi.org/10.1016/j.virusres.2023.199075 Article  CAS  PubMed  PubMed Central  Google Scholar  Goldberg EE, Lin Q, Romero-Severson EO, Ke R. Swift and extensive Omicron outbreak in China after sudden exit from … Read more

Cambridge launches program to tackle engineered pandemic risks

Covid-19 showed us how vulnerable the world is to pandemics – but what if the next pandemic were somehow engineered? How would the world respond – and could we stop it happening in the first place? These are some of the questions being addressed by a new initiative launched today at the University of Cambridge, … Read more

Paxlovid Shows No Benefit in Vaccinated Seniors, Study Shows

TOPLINE: Treatment with Paxlovid in older adults did not appear to make a difference in whether or not they were hospitalized because of COVID-19. METHODOLOGY: Over a 9-month time span starting in April 2022, researchers analyzed the hospital data of over 1.6 million Ontario residents aged 65 to 74 years. Nearly 88% of all patients … Read more

Why life expectancy gains in Europe stalled—and how some countries stayed ahead

New research reveals why life expectancy gains have slowed across Europe—and how proactive policies in some countries helped them weather the COVID-19 crisis better than others. Study: Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. Image Credit: tomertu / Shutterstock In a recent … Read more